dc.creatorAmbrosi, Nella Gabriela
dc.creatorCaro, Fiorella Yanina
dc.creatorOsella, Francisco
dc.creatorAlvarez, Leonardo Diaz
dc.creatorSánchez, Francisco
dc.creatorToniolo, Fernanda
dc.creatorGuerrieri, Diego
dc.creatorIncardona, Claudio
dc.creatorCasadei, Domingo
dc.creatorChuluyan, Hector Eduardo
dc.date.accessioned2020-12-09T17:18:23Z
dc.date.accessioned2022-10-15T01:19:20Z
dc.date.available2020-12-09T17:18:23Z
dc.date.available2022-10-15T01:19:20Z
dc.date.created2020-12-09T17:18:23Z
dc.date.issued2019-08
dc.identifierAmbrosi, Nella Gabriela; Caro, Fiorella Yanina; Osella, Francisco; Alvarez, Leonardo Diaz; Sánchez, Francisco; et al.; SLPI in the perfusion solution helps to identify graft quality in kidney transplants; Future Medicine; Biomarkers In Medicine; 13; 11; 8-2019; 895-906
dc.identifier1752-0363
dc.identifierhttp://hdl.handle.net/11336/120012
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4329179
dc.description.abstractAim: It is important to find biomarkers that identify the graft quality in kidney transplantation. Results & methodology: The level of SLPI in the cold preservation solution was used as a marker to predict early kidney graft function after transplantation. Before transplantation, kidneys were washed and SLPI was measured in the discarded solution. A retrospective analysis showed that patients with delayed graft function or rejection episodes in post-trasplant, had higher SLPI concentrations in the perfusion solution than patients without delayed graft function or rejections. Furthermore, SLPI could discriminate between patients with better or worse estimated glomerular filtration rate among low-risk patients (kidney donor profile index <80). Discussion & conclusion: These results suggest that the SLPI concentration in the perfusion solutions could be a predictor of short-term organ function and a complement to the kidney donor profile index score.
dc.languageeng
dc.publisherFuture Medicine
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.futuremedicine.com/doi/10.2217/bmm-2018-0428
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2217/bmm-2018-0428
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectBIOMARKERS
dc.subjectDECEASED DONORS
dc.subjectDELAY GRAFT FUNCTION
dc.subjectEXPANDED CRITERIA DONORS
dc.subjectKDPI SCORE
dc.subjectKIDNEY TRANSPLANTATION
dc.subjectPERFUSION SOLUTION
dc.subjectSECRETORY LEUKOCYTE PROTEINASE INHIBITOR
dc.titleSLPI in the perfusion solution helps to identify graft quality in kidney transplants
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución